Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial
ERBB 突变与接受阿法替尼或厄洛替尼治疗的肺鳞状细胞癌患者临床结局的相关性:LUX-Lung 8 随机临床试验的二次分析
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.0775
Goss, Glenwood D; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Guclu, Salih; Isla, Dolores; Min, Young Joo; Morabito, Alessandro; Ardizzoni, Andrea; Gadgeel, Shirish M; Fülöp, Andrea; Bühnemann, Claudia; Gibson, Neil; Krämer, Nicole; Solca, Flavio; Cseh, Agnieszka; Ehrnrooth, Eva; Soria, Jean-Charles